GIVAX is a Venture Capital-backed biotech company founded through RA Ventures’ incubator. GIVAX is utilizing a novel vector-based vaccine platform to address unmet public health needs in the prevention of infectious gastrointestinal diseases.

We are not hiring at this time, but if you are interested in future opportunities, please, apply.